The Science

Behind Physiologic Insulin Resensitization​ (PIR)

What is

Physiologic Insulin Resensitization​ (PIR)?

Physiologic Insulin Resensitization is a unique and groundbreaking treatment where insulin is administered as a hormone rather than a drug; addressing the primary cause of Diabetes, metabolic failure. By utilizing insulin in a manner that bio-mimics normal physiology, we are able to reduce insulin resistance, which helps blood sugar more readily enter each cell and be converted into energy.

Increasing cellular energy allows damaged tissues and organs to grow, repair, and regenerate. Thus, our approach not only stabilizes, but in many instances has reversed complications of diabetes and other metabolic disorders.

Glucos-Homeostasis.png

Physiologic Administration

By precision administering insulin in a manner that bio-mimics normal physiology, we are able to up-regulate insulin receptor activity and reduce insulin resistance.

Infusion Treatment

The treatment is designed to reduce insulin resistance, which is the primary cause of type 2 diabetes and other metabolic disorders.

  • The treatment includes an intravenous precision administration of FDA-approved fast-acting insulin using an FDA-approved portable pump.
  • The objective of the precise dosing is to achieve biomimicry of insulin as a hormone communicator to stimulate the metabolism–not to simply use insulin as a drug to suppress a high blood sugar, which typically causes insulin resistance at the insulin receptor level.
  • The pump’s patented biomimicry engineering combined with our patented treatment protocol are designed to administer insulin bioidentically to the body’s way of maintaining an optimized metabolism.
  • Along with the insulin hormone, the patient is given small, specific amounts of glucose (ingested as a dextrose liquid) to stimulate the digestive system and its role in the metabolism process during treatment.
  • Each treatment lasts about two to three hours, and the patient is free to move around the clinic during the treatment.
  • Insulin Sensitization – By achieving insulin sensitivity at the insulin receptor level, glucose can more readily enter cells and be converted into adenosine triphosphate, also known as ATP–a molecule that carries energy within cells.

Experience results that have the potential
to astonish you and your doctor!

Our Patients Report

PLUS: restored energy, medications reduced, diminished nerve pain, diminished retinopathy​, wounds healed, amputations prevented, controlled weight, controlled blood sugar, reduced blood pressure, restored erectile function, improved mood and sleep, and hair and nail growth.

Improved Neuropathy
95%
Report Improvement in at least one diabetic complication
76%
HbA1c Reduction
63%
Reduced diabetic medications
41%

About Nicholas

For the last 10 years, Nicholas Reiter has been working with companies, both large and small, to create and implement systems, processes and training modules throughout their organizations in order to eliminate redundancy and inefficiencies within their companies. Prior to opening his own consulting company, he spent 2 years working with a large construction company that specialized in the building and development (and training) of restaurant franchises. While there, Nick worked as a project manager and other facets of the organization where he was able to fine tune his interpersonal and problem solving skills. He was able to perform macro strategy building while bridging the communication gaps between contractors, laborers and other project managers to create a more efficient process resulting in achieving goals and staying on track with deadlines.

In 2016, he created his own consulting company where he began working with a local hospitals to improve efficiencies within order sets and pre/post-operative communication between staff and physicians, implement standardized order sets to reduce medical errors through communication inefficiencies, improve systemic flow, and create new processes that promote proper patient care techniques. As he continued to grow the company, he was selected to create professional development models, onboarding and training material for all new hires. He helped general contractors and franchises to create new operational efficiencies to lower costs, increase sales and successfully grow their businesses. It is through implementing new company leadership structure, company culture and collaboration skills that he was able to help reduce spending, raise productivity and improve customer satisfaction within each of his clients.

About Raleigh Williams

Raleigh Williams is the marketing coordinator for the Restor Metabolix corporate team. She graduated from Kennesaw State University in 2021 with a major in marketing and minors in sports and engagement marketing. While at Kennesaw State, Raleigh played on the softball team. She was named an All-America Scholar Athlete in 2018 and an Arthur Ashe Jr. Sports Scholar in 2021. In college, Raleigh interned for the Minnesota Vikings in a public relations role for summer training camp. Raleigh began working for RMX in August of 2021, and has worked to grow the clinics’ social media pages, along with provide marketing support. In her free time, Raleigh is a volunteer coach for the Lovett High School softball team.

About Jeffrey Smith

Jeffrey A. Smith was named President and CEO of One Direct Health Network, Inc. and T-Rex Investment, Inc. in April of 2017. Under his leadership, the company has more than doubled its revenues and were EBITDA positive in 2018.  The company is building out a post-operative care “Platform to improve patient outcomes, while reducing cost in the Workers Comp and VA arena.  Prior to accepting this position, he briefly acting as the Chairman of the Executive Committee of Amendia from June, 2016 to January, 2017. As Chairman, Jeff’s responsibilities include mergers and acquisitions, strategic planning, and investing in new IP.  Mr. Smith held the title of Amendia CEO and Director for seven years. Under Jeff’s leadership, Amendia was recognized by multiple awards from Atlanta’s Best And Brightest Companies to Work For, 2016, Atlanta Business Chronicle’s Fast 40 Companies in Atlanta, 2012 and 2013, Deloitte’s Tech Fast 500, 2014 and 2015, and Georgia Manufacturers of the Year, 2014. Under his guidance, Amendia grew from $2.9 million in Revenue to over $82.5 million in seven years and was instrumental in spinning off a biologics company in 2012, Vivex Biomedical, Inc., that will have Revenues in excess of $65 million in 2019. He has held several board seats over the last 8 years which include such companies as Amendia, Inc., Vivex Biomedical, Inc., Valeris Medical, Inc., One Direct Healthcare Services, Inc., DSS, Funding, LLC, Phalanx Technologies, LLC and POE Management, LLC. He is currently acting as Chairman of United in Gaming, Inc. a new E-Sport Gaming Platform “Gather.gg” with a focus on the casual gamers.

 

Before Amendia, Mr. Smith held an Executive Vice President position at Synovus Securities, Inc., which is affiliated with Synovus Financial Corporation (Ticker Symbol on NYSE – SNV), a $30 billion financial institution. Mr. Smith was also a Senior Vice President at Morgan Keegan, Inc., which was owned by the $80 billion Regions Bank (Ticker Symbol on NYSE -RF). His experience included managing the Investment Portfolio, Funding Solutions and interest rate risk in the balance sheets of small to mid-sized financial institutions throughout the U.S. as well as sitting on Synovus Financial Corporation’s Asset/Liability Committee, which oversaw the funding of the balance sheet and the management of their $3 billion fixed income portfolio. Before serving as CEO, Jeff advised over 30 community banks with total fixed income portfolio assets of more than $1.5 billion and provided investment banking services to community banks and their clients. In addition, he has an extensive background in providing alternative funding solutions for small to mid-sized companies and community bank clients throughout the Southeast.

 

Jeff is a graduate of the Georgia Banking School and the University of Georgia, where he received a Bachelor’s Degree in Business Administration with a Major in Finance. Jeff has been married to Amy for 32 years and they have two boys and a daughter-in-law. 

Request a Free Info Pack

Fill out this form to get a free info pack about the groundbreaking treatments that are restoring proper metabolic functions for so many people who’s lives are being changed!